Corvus Pharmaceuticals, Inc.CRVSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank73
3Y CAGR+11.3%
5Y CAGR+1.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+11.3%/yr
vs -10.8%/yr prior
5Y CAGR
+1.2%/yr
Recent acceleration
Acceleration
+22.0pp
Accelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $33.72M | +73.9% |
| 2024 | $19.39M | +17.3% |
| 2023 | $16.53M | -32.5% |
| 2022 | $24.47M | -16.0% |
| 2021 | $29.11M | -8.5% |
| 2020 | $31.83M | -16.2% |
| 2019 | $37.98M | -1.6% |
| 2018 | $38.59M | -16.7% |
| 2017 | $46.30M | +57.7% |
| 2016 | $29.36M | - |